Who owns PMV PHARMACEUTICALS INC?
- Ticker: PMVP
- CUSIP Number: 69353y103
Tip: Access positions for across all investors
Analyze quarterly positions in Pmv Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pmv Pharmaceuticals stock
Who bought or sold PMV PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 5.3M | $6.6M | 0% | Dec 2025 |
|
| OrbiMed Advisors | 5.0M | $6.2M | -17% | Dec 2025 |
|
| Tang Capital Management | 4.9M | $6.2M | 3% | Dec 2025 |
|
| Arrowpoint Asset Management | 3.1M | $3.9M | -6% | Dec 2025 |
|
| Sio Capital Management | 2.6M | $3.3M | 0% | Dec 2025 |
|
| Euclidean Capital | 2.6M | $3.3M | 0% | Dec 2025 |
|
| Vanguard Group | 2.2M | $2.7M | 0% | Dec 2025 |
|
| Acadian Asset Management | 2.0M | $2.5M | -2% | Dec 2025 |
|
| Stonepine Capital Management | 1.2M | $1.4M | -16% | Dec 2025 |
|
| BlackRock | 1.1M | $1.4M | -1% | Dec 2025 |
|
| Two Sigma Advisers | 874k | $1.1M | 109% | Dec 2025 |
|
| Two Sigma Investments | 706k | $883k | 162% | Dec 2025 |
|
| Jacobs Levy Equity Management | 524k | $655k | 664% | Dec 2025 |
|
| Jane Street | 499k | $623k | 31% | Dec 2025 |
|
| Aldebaran Capital | 478k | $598k | -5% | Dec 2025 |
|
| Marshall Wace | 465k | $581k | -24% | Dec 2025 |
|
| Geode Capital Management | 446k | $558k | 3% | Dec 2025 |
|
| Bridgeway Capital Management | 429k | $536k | 34% | Dec 2025 |
|
| Northern Trust | 382k | $478k | 0% | Dec 2025 |
|
| Assenagon Asset Management | 361k | $447k | 157% | Mar 2026 |
|
| Walleye Trading Advisors | 336k | $420k | 21% | Dec 2025 |
|
| State Street Corporation | 183k | $229k | 16% | Dec 2025 |
|
| Rbf Capital | 162k | $203k | -34% | Dec 2025 |
|
| Citadel Advisors | 136k | $170k | -29% | Dec 2025 |
|
| Evoke Wealth | 133k | $166k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 127k | $159k | -26% | Dec 2025 |
|
| XTX Topco | 105k | $131k | 144% | Dec 2025 |
|
| ADAR1 Capital Management | 101k | $126k | 0% | Dec 2025 |
|
| Ikarian Capital | 89k | $111k | -9% | Dec 2025 |
|
| Susquehanna International | 79k | $99k | 207% | Dec 2025 |
|
| Pnc Financial Services | 73k | $92k | 3% | Dec 2025 |
|
| Ameriprise Financial | 65k | $81k | 495% | Dec 2025 |
|
| Seven Fleet Capital Management | 64k | $79k | 100% | Dec 2025 |
|
| Algert Coldiron Investors | 62k | $78k | 0% | Dec 2025 |
|
| Rangeley Capital | 46k | $57k | 0% | Dec 2025 |
|
| Velan Capital Investment Management | 35k | $44k | 0% | Dec 2025 |
|
| Hsbc Holdings | 31k | $39k | 0% | Dec 2025 |
|
| Point72 Asset Management | 29k | $36k | 100% | Dec 2025 |
|
| Simplex Trading | 28k | $35k | 34% | Dec 2025 |
|
| Barclays | 28k | $34k | 0% | Dec 2025 |
|
| Ohio Pers | 27k | $34k | 350% | Dec 2025 |
|
| Boothbay Fund Management | 27k | $34k | -87% | Dec 2025 |
|
| Squarepoint Ops | 27k | $33k | 102% | Dec 2025 |
|
| Two Sigma Securities | 23k | $29k | 100% | Dec 2025 |
|
| Quadrature Capital | 18k | $23k | 100% | Dec 2025 |
|
| Pathstone Holdings | 18k | $22k | 0% | Dec 2025 |
|
| Bailard | 17k | $21k | 100% | Dec 2025 |
|
| Nine Masts Capital | 17k | $21k | 100% | Dec 2025 |
|
| Virtu Financial | 13k | $16k | 100% | Dec 2025 |
|
| Independent Advisor Alliance | 13k | $16k | 0% | Dec 2025 |
|
| Gts Securities | 10k | $13k | 0% | Dec 2025 |
|
| Deerfield Management Company | 8.8k | $11k | 0% | Dec 2025 |
|
| Tower Research Capital | 3.9k | $4.9k | 100% | Dec 2025 |
|
| UBS Group | 1.1k | $1.4k | -29% | Dec 2025 |
|
| Jones Financial Companies, L.L | 1.0k | $1.3k | -2% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 518.00 | $648.018000 | -5% | Dec 2025 |
|
Who sold out of Pmv Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Peapod Lane Capital | Sep 2025 | 203k | $284k |
| PanAgora Asset Management | Sep 2025 | 72k | $101k |
| D. E. Shaw & Co | Sep 2025 | 56k | $78k |
| Dimensional Fund Advisors | Sep 2025 | 16k | $22k |
| Diadema Partners | Sep 2025 | 11k | $16k |
| Persistent Asset Partners | Sep 2025 | 2.6k | $3.6k |